Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 242

1.

Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.

Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF.

JAMA. 2017 Mar 21;317(11):1126-1140. doi: 10.1001/jama.2017.1704.

PMID:
28324093
2.

Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.

Eapen RS, Herlemann A, Washington SL 3rd, Cooperberg MR.

Curr Opin Urol. 2017 Feb 17. doi: 10.1097/MOU.0000000000000383. [Epub ahead of print]

PMID:
28221220
3.

The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort.

Lang MF, Tyson MD, Alvarez JR, Koyama T, Hoffman KE, Resnick MJ, Cooperberg MR, Wu XC, Chen V, Paddock LE, Hamilton AS, Hashibe M, Goodman M, Greenfield S, Kaplan SH, Stroup A, Penson DF, Barocas DA.

Urology. 2017 Feb 9. pii: S0090-4295(17)30123-1. doi: 10.1016/j.urology.2016.12.063. [Epub ahead of print]

PMID:
28189554
4.

Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer.

Lobo JM, Trifiletti DM, Sturz VN, Dicker AP, Buerki C, Davicioni E, Cooperberg MR, Karnes RJ, Jenkins RB, Den RB, Showalter TN.

Clin Genitourin Cancer. 2016 Aug 17. pii: S1558-7673(16)30246-4. doi: 10.1016/j.clgc.2016.08.012. [Epub ahead of print]

PMID:
28089723
5.

Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.

Klaassen Z, Howard LE, de Hoedt A, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ.

Cancer. 2016 Dec 27. doi: 10.1002/cncr.30505. [Epub ahead of print]

PMID:
28026865
6.

Clinically localized prostate cancer in 2017: A review of comparative effectiveness.

Lavery HJ, Cooperberg MR.

Urol Oncol. 2017 Feb;35(2):40-41. doi: 10.1016/j.urolonc.2016.11.013. Review.

PMID:
27998677
7.

Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes.

Leapman MS, Cowan JE, Simko J, Roberge G, Stohr BA, Carroll PR, Cooperberg MR.

Eur Urol. 2016 Dec 8. pii: S0302-2838(16)30884-3. doi: 10.1016/j.eururo.2016.11.032. [Epub ahead of print]

PMID:
27940155
8.

Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy.

Emami NC, Leong L, Wan E, Van Blarigan EL, Cooperberg MR, Tenggara I, Carroll PR, Chan JM, Witte JS, Simko JP.

Prostate. 2017 Mar;77(4):425-434. doi: 10.1002/pros.23283.

PMID:
27900799
9.

Magnetic Resonance Imaging-targeted Prostate Biopsies: Is the Right Technique the Right Question?

Cooperberg MR.

Eur Urol. 2017 Apr;71(4):532-533. doi: 10.1016/j.eururo.2016.10.048. No abstract available.

PMID:
27839778
10.

Re: 10-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.

Cooperberg MR.

Eur Urol. 2017 Mar;71(3):492-493. doi: 10.1016/j.eururo.2016.10.037. No abstract available.

PMID:
27817968
11.

Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.

Tyson MD, Alvarez J, Koyama T, Hoffman KE, Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen VW, Penson DF, Barocas DA.

Eur Urol. 2016 Nov 2. pii: S0302-2838(16)30750-3. doi: 10.1016/j.eururo.2016.10.036. [Epub ahead of print]

PMID:
27816300
12.

What Early ProtecT Results Have Confirmed About Risk-stratified Prostate Cancer Management.

Cooperberg MR.

Eur Urol. 2017 Mar;71(3):389-390. doi: 10.1016/j.eururo.2016.10.017. No abstract available.

PMID:
27815085
13.

Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer.

Wei XX, Chan S, Kwek S, Lewis J, Dao V, Zhang L, Cooperberg MR, Ryan CJ, Lin AM, Friedlander TW, Rini B, Kane C, Simko JP, Carroll PR, Small EJ, Fong L.

Cancer Immunol Res. 2016 Nov;4(11):948-958.

PMID:
27688020
14.

Active Surveillance for Low-Risk Prostate Cancer-An Evolving International Standard of Care.

Cooperberg MR.

JAMA Oncol. 2016 Oct 20. doi: 10.1001/jamaoncol.2016.3179. [Epub ahead of print] No abstract available.

PMID:
27768167
15.

Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.

McKenney JK, Wei W, Hawley S, Auman H, Newcomb LF, Boyer HD, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Tretiakova MS, Vakar-Lopez F, Carroll PR, Cooperberg MR, Gleave ME, Lance RS, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD.

Am J Surg Pathol. 2016 Nov;40(11):1439-1456.

PMID:
27635949
16.

Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.

Leapman MS, Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Walker K, Amling CL, Carroll PR, Cooperberg MR.

J Urol. 2016 Nov;196(5):1408-1414. doi: 10.1016/j.juro.2016.06.086.

PMID:
27352635
17.

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.

Zhao SG, Chang SL, Spratt DE, Erho N, Yu M, Ashab HA, Alshalalfa M, Speers C, Tomlins SA, Davicioni E, Dicker AP, Carroll PR, Cooperberg MR, Freedland SJ, Karnes RJ, Ross AE, Schaeffer EM, Den RB, Nguyen PL, Feng FY.

Lancet Oncol. 2016 Nov;17(11):1612-1620. doi: 10.1016/S1470-2045(16)30491-0.

PMID:
27743920
18.

Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort.

Wadhwa H, Terris MK, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ, Abern MR.

Prostate Cancer Prostatic Dis. 2016 Dec;19(4):423-428. doi: 10.1038/pcan.2016.45.

PMID:
27698440
19.

Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Vidal AC, Howard LE, Sun SX, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ.

Prostate Cancer Prostatic Dis. 2017 Mar;20(1):72-78. doi: 10.1038/pcan.2016.47.

20.

A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy.

Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll PR.

J Urol. 2017 Feb;197(2):369-375. doi: 10.1016/j.juro.2016.08.122.

PMID:
27693447

Supplemental Content

Loading ...
Support Center